Horizon Therapeutics Public - HZNP Short Interest Ratio & Short Volume

Short interest is the volume of Horizon Therapeutics Public shares that have been sold short but have not yet been closed out or covered. As of March 15th, traders have sold 4,040,000 shares of HZNP short. Learn More on Horizon Therapeutics Public's current short interest.

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. HZNP shares currently have a short interest ratio of 2.0. Learn More on Horizon Therapeutics Public's short interest ratio.

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Horizon Therapeutics Public: Parallax Volatility Advisers L.P., Jane Street Group LLC, Squarepoint Ops LLC, Millennium Management LLC, Maven Securities LTD, Nomura Holdings Inc., EHP Funds Inc., Bardin Hill Management Partners LP, Boothbay Fund Management LLC, Centiva Capital LP, Jefferies Financial Group Inc., SG3 Management LLC, Susquehanna International Group LLP, Water Island Capital LLC, Clear Street Markets LLC, Wells Fargo & Company MN, Barclays PLC, JPMorgan Chase & Co., Capstone Investment Advisors LLC, Group One Trading L.P., Cutler Group LLC CA, Simplex Trading LLC, Equitec Proprietary Markets LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Horizon Therapeutics Public saw a increase in short interest in the month of March. As of March 15th, there was short interest totaling 4,040,000 shares, an increase of 23.9% from the previous total of 3,260,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Horizon Therapeutics Public: Jazz Pharmaceuticals plc (3.66%), Zoetis Inc. (0.95%), Genmab A/S (0.47%), Alnylam Pharmaceuticals, Inc. (3.97%), BeiGene, Ltd. (2.09%), BioMarin Pharmaceutical Inc. (3.35%), Catalent, Inc. (3.69%), Sarepta Therapeutics, Inc. (6.18%), Viatris Inc. (1.98%), and United Therapeutics Co. (2.89%).

As of the most recent reporting period, the following stocks had the largest short interest positions: Canadian Natural Resources Limited ($3.66 billion), Occidental Petroleum Co. ($2.62 billion), Coinbase Global, Inc. ($2.38 billion), T. Rowe Price Group, Inc. ($2.13 billion), Verisk Analytics, Inc. ($2.08 billion), Snowflake Inc. ($1.95 billion), Paramount Global ($1.78 billion), Etsy, Inc. ($1.60 billion), Teck Resources Limited ($1.51 billion), and Voya Financial, Inc. ($1.49 billion). View all of the most shorted stocks.

Short selling HZNP is an investing strategy that aims to generate trading profit from Horizon Therapeutics Public as its price is falling. HZNP shares are trading down $0.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Horizon Therapeutics Public occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of HZNP, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including HZNP, twice per month. The most recent reporting period available is March, 15 2023.